Clinical trial
A Randomised Phase II Study Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer
NCT06892860 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Phase II Study Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer
- Lead sponsor
- Queen Mary University of London
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- December 16, 2021
- Completion date
- December 22, 2027
- Enrollment
- 320 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.